Saint-Gingolph, France

Valérie Boujac


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Valérie Boujac: Innovator in Gynecological Treatments

Introduction

Valérie Boujac is a notable inventor based in Saint-Gingolph, France. He has made significant contributions to the field of gynecology through his innovative approaches to treatment. His work focuses on addressing gynecological diseases and the associated symptoms that affect many individuals.

Latest Patents

Valérie Boujac holds a patent for a method aimed at treating gynecological diseases. This invention involves a pharmaceutical combination that includes co-administering a suitable composition for oral administration, which comprises a first progesterone receptor modulator. Additionally, it includes a pharmaceutical composition suitable for vaginal and/or intrauterine administration, which contains a second progesterone receptor modulator. This innovative approach has the potential to improve treatment outcomes for patients suffering from gynecological conditions.

Career Highlights

Throughout his career, Valérie Boujac has been associated with Preglem SA, a company dedicated to advancing women's health. His work at Preglem has allowed him to focus on developing effective treatments that address critical health issues faced by women. His dedication to research and innovation has positioned him as a key figure in the field.

Collaborations

Valérie Boujac has collaborated with esteemed colleagues such as Jean-Pierre Gotteland and Ernest Loumaye. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately enhancing the quality of research and development in gynecological treatments.

Conclusion

Valérie Boujac's contributions to gynecological health through his innovative patent demonstrate his commitment to improving patient care. His work continues to influence the field and offers hope for better treatment options for those affected by gynecological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…